2-amino-5-phosphonovalerate has been researched along with tacrolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, K; Li, ST; Mikoshiba, K | 1 |
Caruana, DA; Chapman, CA; Glasgow, SD; Kourrich, S | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and tacrolimus
Article | Year |
---|---|
High Ca(2+)/low Mg(2+) solution induces long-term depression in rat CA1 pyramidal neurons.
Topics: 2-Amino-5-phosphonovalerate; Animals; Benzoates; Calcium; Calcium Channel Blockers; Electric Stimulation; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; In Vitro Techniques; Magnesium; Neuronal Plasticity; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Sirolimus; Solutions; Tacrolimus; Verapamil | 2000 |
Postsynaptic signals mediating induction of long-term synaptic depression in the entorhinal cortex.
Topics: 2-Amino-5-phosphonovalerate; Animals; Calcineurin; Calcium Signaling; Cyclosporine; Dizocilpine Maleate; Entorhinal Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Long-Term Synaptic Depression; Male; Neurons; Okadaic Acid; Patch-Clamp Techniques; Protein Phosphatase 1; Pyramidal Cells; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Tacrolimus | 2008 |